Ferring Pharmaceuticals Opens State-of-the-Art Global Manufacturing Hub in Finland
Ferring Pharmaceuticals announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin (nadofaragene firadenovec-vncg). This represents a significant milestone in Ferring’s capabilities and capacity to meet the current…
